2014 Q3 Form 10-K Financial Statement
#000114420415007770 Filed on February 11, 2015
Income Statement
| Concept | 2014 Q3 | 2013 Q4 | 2013 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $55.45K | $2.330M | |
| YoY Change | 6.68% | ||
| % of Gross Profit | |||
| Research & Development | $162.6K | $1.276M | |
| YoY Change | -13.96% | ||
| % of Gross Profit | |||
| Depreciation & Amortization | $0.00 | $2.000K | |
| YoY Change | 0.0% | ||
| % of Gross Profit | |||
| Operating Expenses | $218.0K | $3.606M | |
| YoY Change | -1.66% | ||
| Operating Profit | -$218.0K | -$3.606M | |
| YoY Change | -1.66% | ||
| Interest Expense | $2.882K | -$10.00K | |
| YoY Change | -98.33% | ||
| % of Operating Profit | |||
| Other Income/Expense, Net | -$5.100K | -$14.00K | |
| YoY Change | -97.67% | ||
| Pretax Income | -$223.1K | -$3.620M | |
| YoY Change | -15.22% | ||
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$223.1K | -$3.620M | |
| YoY Change | -15.18% | ||
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$2.999K | -$171.7K | |
| COMMON SHARES | |||
| Basic Shares Outstanding | 73.37M shares | 21.08M shares | |
| Diluted Shares Outstanding | 73.37M shares | 21.08M shares |
Balance Sheet
| Concept | 2014 Q3 | 2013 Q4 | 2013 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $7.660M | ||
| YoY Change | 596.36% | ||
| Cash & Equivalents | $52.61K | $553.7K | $7.660M |
| Short-Term Investments | |||
| Other Short-Term Assets | |||
| YoY Change | |||
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $180.0K | ||
| Other Receivables | $0.00 | ||
| Total Short-Term Assets | $7.832M | $7.830M | |
| YoY Change | 599.11% | ||
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $0.00 | $0.00 | |
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | |||
| YoY Change | |||
| Total Long-Term Assets | $0.00 | $0.00 | |
| YoY Change | |||
| TOTAL ASSETS | |||
| Total Short-Term Assets | $7.832M | $7.830M | |
| Total Long-Term Assets | $0.00 | $0.00 | |
| Total Assets | $7.832M | $7.830M | |
| YoY Change | 599.11% | ||
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $650.0K | ||
| YoY Change | -61.76% | ||
| Accrued Expenses | $403.0K | ||
| YoY Change | |||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | ||
| YoY Change | -100.0% | ||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.231M | $1.230M | |
| YoY Change | -68.05% | ||
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | ||
| YoY Change | |||
| Other Long-Term Liabilities | $0.00 | $790.0K | |
| YoY Change | 25.4% | ||
| Total Long-Term Liabilities | $787.0K | $790.0K | |
| YoY Change | 25.4% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.231M | $1.230M | |
| Total Long-Term Liabilities | $787.0K | $790.0K | |
| Total Liabilities | $2.018M | $2.020M | |
| YoY Change | -54.91% | ||
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$20.54M | ||
| YoY Change | |||
| Common Stock | $26.36M | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $400.7K | $5.810M | |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $7.832M | $7.830M | |
| YoY Change | 599.11% |
Cashflow Statement
| Concept | 2014 Q3 | 2013 Q4 | 2013 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$223.1K | -$3.620M | |
| YoY Change | -15.18% | ||
| Depreciation, Depletion And Amortization | $0.00 | $2.000K | |
| YoY Change | 0.0% | ||
| Cash From Operating Activities | $3.570M | -$5.450M | |
| YoY Change | 155.39% | ||
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | ||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $140.0K | ||
| YoY Change | |||
| Cash From Investing Activities | $140.0K | $0.00 | |
| YoY Change | |||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $0.00 | ||
| YoY Change | -100.0% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -7.880M | $12.00M | |
| YoY Change | 271.38% | ||
| NET CHANGE | |||
| Cash From Operating Activities | 3.570M | -$5.450M | |
| Cash From Investing Activities | 140.0K | $0.00 | |
| Cash From Financing Activities | -7.880M | $12.00M | |
| Net Change In Cash | -4.170M | $6.553M | |
| YoY Change | 496.81% | ||
| FREE CASH FLOW | |||
| Cash From Operating Activities | $3.570M | -$5.450M | |
| Capital Expenditures | $0.00 | ||
| Free Cash Flow | -$5.450M | ||
| YoY Change | 155.39% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7657000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6216000 | USD |
| CY2013Q4 | cltx |
Accounts Receivable And Prepaid Expenses Net Current
AccountsReceivableAndPrepaidExpensesNetCurrent
|
175000 | USD |
| CY2014Q4 | cltx |
Accounts Receivable And Prepaid Expenses Net Current
AccountsReceivableAndPrepaidExpensesNetCurrent
|
73000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
7832000 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
6431000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
0 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
49000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1231000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
7832000 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
6480000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
652000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1003000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
579000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
356000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1359000 | USD |
| CY2013Q4 | cltx |
Liability Related To Stock Options And Warrants
LiabilityRelatedToStockOptionsAndWarrants
|
787000 | USD |
| CY2014Q4 | cltx |
Liability Related To Stock Options And Warrants
LiabilityRelatedToStockOptionsAndWarrants
|
235000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
787000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
268000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
675000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
927000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
25681000 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
34116000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-20542000 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30190000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5814000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4853000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7832000 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6480000 | USD |
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0in 0in 0pt 28.35pt"> </div> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 56.7pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="76"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 28.35pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="38"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">a.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Use of estimates:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 60.9pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5000000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
40227953 | shares |
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"></div> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 56.7pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="76"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 28.35pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="38"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">j.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Concentrations of credit risk:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
55636283 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
40227953 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
55636283 | shares |
| CY2012 | us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
418000 | USD |
| CY2013 | us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
270000 | USD |
| CY2014 | us-gaap |
Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
|
549000 | USD |
| CY2013 | cltx |
Cumulative Basis For Measurement Of Tax Benefits
CumulativeBasisForMeasurementOfTaxBenefits
|
0.5 | pure |
| CY2014 | cltx |
Cumulative Basis For Measurement Of Tax Benefits
CumulativeBasisForMeasurementOfTaxBenefits
|
0.5 | pure |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
67000 | USD |
| CY2013 | us-gaap |
Depreciation
Depreciation
|
2000 | USD |
| CY2014 | us-gaap |
Depreciation
Depreciation
|
8000 | USD |
| CY2013 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
3000 | USD |
| CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1483000 | USD |
| CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1276000 | USD |
| CY2014 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6417000 | USD |
| CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2184000 | USD |
| CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2330000 | USD |
| CY2014 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3760000 | USD |
| CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3667000 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3606000 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10177000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-601000 | USD |
| CY2013 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-14000 | USD |
| CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
529000 | USD |
| CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4268000 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3620000 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-9648000 | USD |
| CY2012 | cltx |
Deemed Dividend
DeemedDividend
|
33000 | USD |
| CY2013 | cltx |
Deemed Dividend
DeemedDividend
|
0 | USD |
| CY2014 | cltx |
Deemed Dividend
DeemedDividend
|
0 | USD |
| CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4301000 | USD |
| CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-3620000 | USD |
| CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-9648000 | USD |
| CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.35 | |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.17 | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.18 | |
| CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
403000 | USD |
| CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
352000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
176000 | USD |
| CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4000 | USD |
| CY2013 | cltx |
Minimum Rental Commitments
MinimumRentalCommitments
|
500 | USD |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
770527 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1570000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
845000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
137300 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2203227 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2903227 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
2903227 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1490727 | shares |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.44 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.82 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.70 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1.51 | |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.71 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.42 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
1.42 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.39 | |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y2M12D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y7M6D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y2M12D | |
| CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
169000 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | USD |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2485000 | USD |
| CY2013 | cltx |
Stock Issued During Period Value Capital And Warrants
StockIssuedDuringPeriodValueCapitalAndWarrants
|
1056000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1937000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
11617000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
8219000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
450000 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
94000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
412000 | USD |
| CY2012 | cltx |
Receipts On Accounts Of Shares
ReceiptsOnAccountsOfShares
|
118000 | USD |
| CY2012 | cltx |
Adjustments To Additional Paid In Capital Expiration Of Deferred Shares
AdjustmentsToAdditionalPaidInCapitalExpirationOfDeferredShares
|
128000 | USD |
| CY2012 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
25000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
56000 | USD |
| CY2012 | cltx |
Adjustments To Additional Paid In Capital Classification Of Warrants From Liability To Equity Result Of Modification
AdjustmentsToAdditionalPaidInCapitalClassificationOfWarrantsFromLiabilityToEquityResultOfModification
|
35000 | USD |
| CY2012 | cltx |
Adjustments To Additional Paid In Capital Classification Of Warrants From Liability To Equity Result Of Most Favored Nation Terms
AdjustmentsToAdditionalPaidInCapitalClassificationOfWarrantsFromLiabilityToEquityResultOfMostFavoredNationTerms
|
141000 | USD |
| CY2013 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
40000 | USD |
| CY2012 | cltx |
Adjustments To Additional Paid In Capital Conversion Of Trade Payable Into Warrants
AdjustmentsToAdditionalPaidInCapitalConversionOfTradePayableIntoWarrants
|
309000 | USD |
| CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
250000 | USD |
| CY2012 | cltx |
Deemed Dividend Related To Modification Of Warrants
DeemedDividendRelatedToModificationOfWarrants
|
0 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3360000 | USD |
| CY2013 | cltx |
Classification Of Warrants Value From Liability To Equity Result Of Investors Exercise Of Most Favored Nation Terms
ClassificationOfWarrantsValueFromLiabilityToEquityResultOfInvestorsExerciseOfMostFavoredNationTerms
|
27000 | USD |
| CY2013 | cltx |
Stock Issued During Period Value Due To Price Protection Provision
StockIssuedDuringPeriodValueDueToPriceProtectionProvision
|
0 | USD |
| CY2014Q4 | cltx |
Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
|
578135 | shares |
| CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
385000 | USD |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
74000 | USD |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
410000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
15333300 | shares |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q1 | us-gaap |
Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
|
0.60 | |
| CY2014Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
981000 | USD |
| CY2012Q4 | cltx |
Receivable On Account Of Shares
ReceivableOnAccountOfShares
|
75000 | USD |
| CY2012 | cltx |
Warrants Granted To Purchase Ordinary Shares
WarrantsGrantedToPurchaseOrdinaryShares
|
1269164 | shares |
| CY2014 | cltx |
Warrants Granted To Purchase Ordinary Shares
WarrantsGrantedToPurchaseOrdinaryShares
|
2.00 | shares |
| CY2012 | cltx |
Description Of Purchase Agreement From Each Investor
DescriptionOfPurchaseAgreementFromEachInvestor
|
(i) the two year anniversary of the effective date of a registration statement (which will be April, 2015) or (ii) the date immediately following the 20 consecutive trading days wherein the trading volume for the Ordinary Shares or ADSs exceeds $ 100 per trading day, each investor may elect to exchange all of its shares and warrants for any such additional securities issued by the Company in a subsequent financing (as defined in the 2012 Purchase Agreements), on the same terms and conditions as provided to the investors in a subsequent financing on a $ 1 for $ 1 basis, in lieu of cash consideration (the "Most Favored Nation Terms"). | |
| CY2014Q4 | cltx |
Initial Fair Value Of Detachable Warrant Granted
InitialFairValueOfDetachableWarrantGranted
|
2873310000 | USD |
| CY2007Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1365000 | shares |
| CY2014Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
313000 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y6M18D | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2988 | shares | |
| CY2009Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
30000 | shares |
| CY2007Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
20475 | shares |
| CY2014Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
35000 | shares |
| CY2012 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
2000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
412000 | USD |
| CY2009Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
33000 | USD |
| CY2007Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
29000 | USD |
| CY2013 | cltx |
Financial Income
FinancialIncome
|
20000 | USD |
| CY2014 | cltx |
Financial Income
FinancialIncome
|
2000 | USD |
| CY2011 | cltx |
Warrants Granted
WarrantsGranted
|
35000 | shares |
| CY2012Q1 | cltx |
Warrants Granted
WarrantsGranted
|
10000 | shares |
| CY2011 | cltx |
Warrants Granted Exercise Price Per Share
WarrantsGrantedExercisePricePerShare
|
1 | |
| CY2012Q1 | cltx |
Warrants Granted Exercise Price Per Share
WarrantsGrantedExercisePricePerShare
|
1 | |
| CY2011 | cltx |
Warrants Granted Value
WarrantsGrantedValue
|
45000 | USD |
| CY2012Q1 | cltx |
Warrants Granted Value
WarrantsGrantedValue
|
12000 | USD |
| CY2012Q2 | cltx |
Warrants Granted Value
WarrantsGrantedValue
|
38000 | USD |
| CY2012Q1 | cltx |
Warrants Vested To Purchase Ordinary Shares
WarrantsVestedToPurchaseOrdinaryShares
|
309492 | shares |
| CY2012Q1 | cltx |
Warrants Vested To Purchase Ordinary Shares Per Share
WarrantsVestedToPurchaseOrdinarySharesPerShare
|
0.01 | |
| cltx |
Warrants Issued To Agent Value
WarrantsIssuedToAgentValue
|
90180000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
120000 | USD | |
| CY2014Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
8219000 | USD |
| CY2014Q1 | cltx |
Average Daily Volume Of Ordinary Shares
AverageDailyVolumeOfOrdinaryShares
|
75000 | shares |
| CY2011 | cltx |
Warrants Granted To Purchase Ordinary Shares Contractual Life
WarrantsGrantedToPurchaseOrdinarySharesContractualLife
|
P5Y | |
| CY2012Q1 | cltx |
Warrants Granted To Purchase Ordinary Shares Contractual Life
WarrantsGrantedToPurchaseOrdinarySharesContractualLife
|
P5Y | |
| CY2013Q3 | cltx |
Additional Stock Issuable On Exercise Of Warrants
AdditionalStockIssuableOnExerciseOfWarrants
|
1259092 | shares |
| CY2014 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
0 | USD |
| CY2012 | cltx |
Other Nonoperating Expense Other
OtherNonoperatingExpenseOther
|
6000 | USD |
| CY2014 | cltx |
Common Stock Capital Shares Reserved For Future Issuance Under Most Favoured Nations Terms
CommonStockCapitalSharesReservedForFutureIssuanceUnderMostFavouredNationsTerms
|
5659717 | shares |
| CY2014 | cltx |
Common Stock Capital Shares Reserved For Future Issuance Under Price Protection
CommonStockCapitalSharesReservedForFutureIssuanceUnderPriceProtection
|
5089544 | shares |
| CY2014 | cltx |
Warrants Stock Reserved For Future Issuance Under Price Protection
WarrantsStockReservedForFutureIssuanceUnderPriceProtection
|
729450 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1929824 | shares |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0.34 | pure |
| CY2012 | cltx |
Taxable Income Maximum
TaxableIncomeMaximum
|
300000 | GBP |
| CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2 | pure |
| CY2012 | cltx |
Estimated Tax Rate
EstimatedTaxRate
|
0.4 | pure |
| CY2012Q4 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
|
630000 | USD |
| CY2013 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
286000 | USD |
| CY2014 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
552000 | USD |
| CY2013 | cltx |
Fair Value Instruments Classified In Shareholders Equity Measured On Recurring Basis Issuance Of Liability Related To Warrants
FairValueInstrumentsClassifiedInShareholdersEquityMeasuredOnRecurringBasisIssuanceOfLiabilityRelatedToWarrants
|
471000 | USD |
| CY2013 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
-28000 | USD |
| CY2013Q4 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
|
787000 | USD |
| CY2014Q4 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
|
235000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
330000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
118000 | USD |
| CY2012 | us-gaap |
Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
|
365000 | USD |
| CY2013 | us-gaap |
Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
|
555000 | USD |
| CY2014 | us-gaap |
Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
|
749000 | USD |
| CY2012 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
898000 | USD |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
202000 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2012 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
137000 | USD |
| CY2013 | cltx |
Other Nonoperating Expense Other
OtherNonoperatingExpenseOther
|
42000 | USD |
| CY2014 | cltx |
Other Nonoperating Expense Other
OtherNonoperatingExpenseOther
|
20000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
1041000 | USD |
| CY2013 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
284000 | USD |
| CY2014 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
20000 | USD |
| CY2012 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
440000 | USD |
| CY2013 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
270000 | USD |
| CY2014 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
549000 | USD |
| CY2013 | us-gaap |
Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
|
0.57 | |
| CY2014 | us-gaap |
Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
|
0.60 | |
| CY2012 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
514000 | USD |
| CY2013 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
94000 | USD |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
468000 | USD |
| CY2012 | us-gaap |
Depreciation
Depreciation
|
2000 | USD |
| CY2012 | cltx |
Increase Decrease In Values Of Deferred Shares And Liability Related To Stock Options And Warrants
IncreaseDecreaseInValuesOfDeferredSharesAndLiabilityRelatedToStockOptionsAndWarrants
|
418000 | USD |
| CY2013 | cltx |
Increase Decrease In Values Of Deferred Shares And Liability Related To Stock Options And Warrants
IncreaseDecreaseInValuesOfDeferredSharesAndLiabilityRelatedToStockOptionsAndWarrants
|
286000 | USD |
| CY2014 | cltx |
Increase Decrease In Values Of Deferred Shares And Liability Related To Stock Options And Warrants
IncreaseDecreaseInValuesOfDeferredSharesAndLiabilityRelatedToStockOptionsAndWarrants
|
552000 | USD |
| CY2012 | cltx |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
-7000 | USD |
| CY2013 | cltx |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
161000 | USD |
| CY2014 | cltx |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
-102000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
627000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-1045000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
351000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
394000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-676000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-223000 | USD |
| CY2012 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1008000 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
242000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
57000 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2134000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5450000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9461000 | USD |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
6553000 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1441000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1104000 | USD |
| CY2013Q4 | us-gaap |
Other Restricted Assets Current
OtherRestrictedAssetsCurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Other Restricted Assets Current
OtherRestrictedAssetsCurrent
|
142000 | USD |
| CY2012 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-199000 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
2224000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
13103000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
8219000 | USD |
| CY2012 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
890000 | USD |
| CY2013 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
| CY2012 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
| CY2013 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
1100000 | USD |
| CY2014 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
0 | USD |
| CY2012 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
118000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3232000 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12003000 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8219000 | USD |
| CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1098000 | USD |
| CY2012 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12458874 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21075065 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
54116557 | shares |
| CY2012 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12458874 | shares |
| CY2013 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21075065 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
54271330 | shares |
| CY2012 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
33000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
| CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
33000 | USD |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-12-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
Celsus Therapeutics Plc. | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001541157 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2014Q2 | dei |
Entity Public Float
EntityPublicFloat
|
34494495 | USD |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
CLTX | |
| CY2015Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
55636283 | shares |
| CY2013 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
0 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
297000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
289000 | USD |
| CY2014 | us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
142000 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
145000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.61 | |
| CY2012 | cltx |
Other Nonoperating Income Other
OtherNonoperatingIncomeOther
|
22000 | USD |
| CY2013 | cltx |
Other Nonoperating Income Other
OtherNonoperatingIncomeOther
|
0 | USD |
| CY2014 | cltx |
Other Nonoperating Income Other
OtherNonoperatingIncomeOther
|
0 | USD |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
313000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
330000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
225000 | USD |
| CY2014Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1454000 | USD |
| CY2014 | us-gaap |
Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
|
1561000 | USD |
| CY2012 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
207548 | GBP |
| CY2012 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
322000 | USD |
| CY2013 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
155795 | GBP |
| CY2013 | us-gaap |
Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
|
242000 | USD |
| CY2014Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
56000 | USD |
| CY2014Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
0.57 |
